Maren M. Sjaastad Andreassen

Maren M. Sjaastad Andreassen

Auto-generated profile, based on publicly available information

Maren M. Sjaastad Andreassen

Department of Circulation and Medical Imaging NTNU Norwegian University of Science and Technology Trondheim Norway

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2020 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
MAMaren M. Sjaastad Andreassen
Maren M. Sjaastad Andreassen
ARAna E. Rodríguez-Soto
Ana E. Rodríguez-Soto
CCChristopher C. Conlin
Christopher C. Conlin
IVIgor Vidić
Igor Vidić
TSTyler M. Seibert
Tyler M. Seibert
ADAnders M. Dale
Anders M. Dale
Purpose: Diffusion-weighted MRI (DW-MRI) is a contrast-free modality that has demonstrated ability to discriminate between predefined benign and malignant breast lesions. However, how well DW-MRI discriminates cancer from all other breast tissue voxels in a clinical setting is unknown. Here we explore the voxelwise ability to distinguish cancer from healthy breast tissue using signal contributions from the newly developed three-component multi-b-value DW-MRI model. Experimental Design: Patients with pathology-proven breast cancer from two datasets (n = 81 and n = 25) underwent multi-b-value DW-MRI. The three-component signal contributions C1 and C2 and their product, C1C2, and signal fractions F1, F2, and F1F2 were compared with the image defined on maximum b-value (DWImax), conventional apparent diffusion coefficient (ADC), and apparent diffusion kurtosis (Kapp). The ability to discriminate between cancer and healthy breast tissue was assessed by the false-positive rate given a sensitivity of 80% (FPR80) and ROC AUC. Results: Mean FPR80 for both datasets was 0.016 [95% confidence interval (CI), 0.008–0.024] for C1C2, 0.136 (95% CI, 0.092–0.180) for C1, 0.068 (95% CI, 0.049–0.087) for C2, 0.462 (95% CI, 0.425–0.499) for F1F2, 0.832 (95% CI, 0.797–0.868) for F1, 0.176 (95% CI, 0.150–0.203) for F2, 0.159 (95% CI, 0.114–0.204) for DWImax, 0.731 (95% CI, 0.692–0.770) for ADC, and 0.684 (95% CI, 0.660–0.709) for Kapp. Mean ROC AUC for C1C2 was 0.984 (95% CI, 0.977–0.991). Conclusions: The C1C2 parameter of the three-component model yields a clinically useful discrimination between cancer and healthy breast tissue, superior to other DW-MRI methods and obliviating predefining lesions. This novel DW-MRI method may serve as noncontrast alternative to standard-of-care dynamic contrast-enhanced MRI.

14 December 2021 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
ARAna E. Rodríguez‐Soto
Ana E. Rodríguez‐Soto
MAMaren M. Sjaastad Andreassen
Maren M. Sjaastad Andreassen
LFLauren Kristen Fang
Lauren Kristen Fang
CCChristopher C. Conlin
Christopher C. Conlin
HPHelen H. Park
Helen H. Park
ADAnders M. Dale
Anders M. Dale

31 March 2023
Verified
Other
Open access
MAMaren M. Sjaastad Andreassen
Maren M. Sjaastad Andreassen
ARAna E. Rodríguez-Soto
Ana E. Rodríguez-Soto
CCChristopher C. Conlin
Christopher C. Conlin
IVIgor Vidić
Igor Vidić
TSTyler M. Seibert
Tyler M. Seibert
ADAnders M. Dale
Anders M. Dale
Probability density colormaps for the three-component model given C1 and C2 for all voxels per patient for (A.) cancer (cancer ROI) and (B.) healthy breast tissue (control ROI).

31 March 2023
Verified
Other
Open access
MAMaren M. Sjaastad Andreassen
Maren M. Sjaastad Andreassen
ARAna E. Rodríguez-Soto
Ana E. Rodríguez-Soto
CCChristopher C. Conlin
Christopher C. Conlin
IVIgor Vidić
Igor Vidić
TSTyler M. Seibert
Tyler M. Seibert
ADAnders M. Dale
Anders M. Dale
Mean (95% CI) for all performance measures the U.S. dataset (Supplementary Table S1) and European dataset (Supplementary Table S2). Median (interquartile range) for average signal of the cancer and control regions of interests (ROIs) for both datasets combined (Supplementary Table S3).

31 March 2023
Verified
Other
Open access
MAMaren M. Sjaastad Andreassen
Maren M. Sjaastad Andreassen
ARAna E. Rodríguez-Soto
Ana E. Rodríguez-Soto
CCChristopher C. Conlin
Christopher C. Conlin
IVIgor Vidić
Igor Vidić
TSTyler M. Seibert
Tyler M. Seibert
ADAnders M. Dale
Anders M. Dale
Purpose:Diffusion-weighted MRI (DW-MRI) is a contrast-free modality that has demonstrated ability to discriminate between predefined benign and malignant breast lesions. However, how well DW-MRI discriminates cancer from all other breast tissue voxels in a clinical setting is unknown. Here we explore the voxelwise ability to distinguish cancer from healthy breast tissue using signal contributions from the newly developed three-component multi-b-value DW-MRI model.Experimental Design:Patients with pathology-proven breast cancer from two datasets (n = 81 and n = 25) underwent multi-b-value DW-MRI. The three-component signal contributions C1 and C2 and their product, C1C2, and signal fractions F1, F2, and F1F2 were compared with the image defined on maximum b-value (DWImax), conventional apparent diffusion coefficient (ADC), and apparent diffusion kurtosis (Kapp). The ability to discriminate between cancer and healthy breast tissue was assessed by the false-positive rate given a sensitivity of 80% (FPR80) and ROC AUC.Results:Mean FPR80 for both datasets was 0.016 [95% confidence interval (CI), 0.008–0.024] for C1C2, 0.136 (95% CI, 0.092–0.180) for C1, 0.068 (95% CI, 0.049–0.087) for C2, 0.462 (95% CI, 0.425–0.499) for F1F2, 0.832 (95% CI, 0.797–0.868) for F1, 0.176 (95% CI, 0.150–0.203) for F2, 0.159 (95% CI, 0.114–0.204) for DWImax, 0.731 (95% CI, 0.692–0.770) for ADC, and 0.684 (95% CI, 0.660–0.709) for Kapp. Mean ROC AUC for C1C2 was 0.984 (95% CI, 0.977–0.991).Conclusions:The C1C2 parameter of the three-component model yields a clinically useful discrimination between cancer and healthy breast tissue, superior to other DW-MRI methods and obliviating predefining lesions. This novel DW-MRI method may serve as noncontrast alternative to standard-of-care dynamic contrast-enhanced MRI.

31 March 2023
Verified
Other
Open access
MAMaren M. Sjaastad Andreassen
Maren M. Sjaastad Andreassen
ARAna E. Rodríguez-Soto
Ana E. Rodríguez-Soto
CCChristopher C. Conlin
Christopher C. Conlin
IVIgor Vidić
Igor Vidić
TSTyler M. Seibert
Tyler M. Seibert
ADAnders M. Dale
Anders M. Dale
Probability density colormaps for the three-component model given C1 and C2 for all voxels per patient for (A.) cancer (cancer ROI) and (B.) healthy breast tissue (control ROI).